Suppr超能文献

罗卡胍类化合物的翻译抑制作用激活了新兴真菌病原体耳念珠菌中的一种种特异性细胞死亡程序。

Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris.

机构信息

Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Department of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, Massachusetts, USA.

出版信息

mBio. 2020 Mar 10;11(2):e03329-19. doi: 10.1128/mBio.03329-19.

Abstract

Fungal infections are a major contributor to infectious disease-related deaths worldwide. Recently, global emergence of the fungal pathogen has caused considerable concern because most isolates are resistant to fluconazole, the most commonly administered antifungal, and some isolates are resistant to drugs from all three major antifungal classes. To identify novel agents with bioactivity against , we screened 2,454 compounds from a diversity-oriented synthesis collection. Of the five hits identified, most shared a common rocaglate core structure and displayed fungicidal activity against These rocaglate hits inhibited translation in but not in its pathogenic relative Species specificity was contingent on variation at a single amino acid residue in Tif1, a fungal member of the eukaryotic initiation factor 4A (eIF4A) family of translation initiation factors known to be targeted by rocaglates. Rocaglate-mediated inhibition of translation in activated a cell death program characterized by loss of mitochondrial membrane potential, increased caspase-like activity, and disrupted vacuolar homeostasis. In a rocaglate-sensitized mutant engineered to express translation initiation factor 1 (Tif1) with the variant amino acid that we had identified in , translation was inhibited but no programmed cell death phenotypes were observed. This surprising finding suggests divergence between these related fungal pathogens in their pathways of cellular responses to translation inhibition. From a therapeutic perspective, the chemical biology that we have uncovered reveals species-specific vulnerability in and identifies a promising target for development of new, mechanistically distinct antifungals in the battle against this emerging pathogen. Emergence of the fungal pathogen has ignited intrigue and alarm within the medical community and the public at large. This pathogen is unusually resistant to antifungals, threatening to overwhelm current management options. By screening a library of structurally diverse molecules, we found that is surprisingly sensitive to translation inhibition by a class of compounds known as rocaglates (also known as flavaglines). Despite the high level of conservation across fungi in their protein synthesis machinery, these compounds inhibited translation initiation and activated a cell death program in but not in its relative Our findings highlight a surprising divergence across the cell death programs operating in species and underscore the need to understand the specific biology of a pathogen in attempting to develop more-effective treatments against it.

摘要

真菌感染是全球传染病相关死亡的主要原因。最近,真菌病原体的全球出现引起了相当大的关注,因为大多数分离株对最常使用的抗真菌药物氟康唑耐药,而一些分离株对所有三大类抗真菌药物都耐药。为了寻找对有生物活性的新型药物,我们从多样性导向合成库中筛选了 2454 种化合物。在鉴定出的 5 个命中化合物中,大多数具有共同的罗卡莱特核心结构,并对表现出杀菌活性。这些罗卡莱特命中化合物抑制但不抑制其致病相关的翻译。种特异性取决于真菌起始因子 4A (eIF4A)家族中的翻译起始因子 Tif1 中的单个氨基酸残基的变异,已知罗卡莱特靶向该因子。罗卡莱特在中抑制翻译激活了一个以线粒体膜电位丧失、半胱氨酸蛋白酶样活性增加和液泡动态平衡破坏为特征的细胞死亡程序。在一个表达我们在中鉴定出的变异氨基酸的罗卡莱特敏感突变体中,翻译被抑制,但没有观察到程序性细胞死亡表型。这一惊人的发现表明,这些相关真菌病原体在其对翻译抑制的细胞反应途径中存在分歧。从治疗的角度来看,我们揭示的化学生物学揭示了在中的种特异性脆弱性,并确定了一个有希望的目标,用于开发针对这种新兴病原体的新型、机制上不同的抗真菌药物。真菌病原体的出现激起了医学界和广大公众的好奇和警惕。这种病原体对抗真菌药物异常耐药,威胁到当前的管理选择。通过筛选一个结构多样的分子文库,我们发现一种称为罗卡莱特(也称为 flavaglines)的化合物对的翻译抑制非常敏感。尽管真菌在其蛋白质合成机制中高度保守,但这些化合物抑制了的翻译起始,并激活了细胞死亡程序,但在其相对的中没有。我们的研究结果突出了在 物种中细胞死亡程序的惊人差异,并强调了在试图开发更有效的治疗方法时了解病原体的具体生物学的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5441/7064782/36aba4b325ea/mBio.03329-19-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验